Purdue Pharma and Geisinger launch wearable tech study of chronic pain patients

Purdue Pharma and integrated health company Geisinger Health Systems said today they launched a joint study looking to evaluate the effect of wearable health tech on treating patients with chronic pain. Through the study, the companies hope to explore the use of wearable health tech by chronic pain patients at a specialty clinic and evaluate how the tech improves patient and healthcare outcomes, Stamford, Conn.-based Purdue Pharma said. The prospective, non-randomized, non-blinded 12-month trial aims to enroll 240 multidisciplinary pain-program patients being treated by Geisinger and includes a wearable device designed to guide patients towards non-pharmaceutical treatments including stretching, mindfulness and thermotherapy, the company said. “The goal of this technology is to improve patient function and quality of life while reducing the need for analgesic medications. It provides objective measures of numerous aspects of pain, function and treatment effectiveness so that information can be gathered for the patient and the healthcare provider in between visits. We are pleased to partner with Geisinger on this important initiative and believe real-time data may have the potential to support an improved understanding of chronic pain patients’ experiences and needs,” Purdue Pharma medial affairs strategic research head Dr. Tracy Mayne said in a press release. Wearable tech undergoing analysis will include an Apple Watch designed to measure physical activity, pat...
Source: Mass Device - Category: Medical Devices Authors: Tags: Clinical Trials mHealth (Mobile Health) Pain Management Patient Monitoring Geisinger Health System purduepharma Source Type: news